Literature DB >> 11991439

Evaluation of osteoporosis treatment in seniors after hip fracture.

A G Juby1, C M De Geus-Wenceslau.   

Abstract

A retrospective chart review was carried out on all consecutive patients over 65 years of age admitted to a tertiary care teaching hospital with a diagnosis of a new hip fracture. A further chart review occurred after discharge from post-surgery rehabilitation. The primary objective was to evaluate the prevalence of osteoporosis diagnosis and treatment in both phases of the study. Secondary objectives included evaluation of the mortality rates, length of stay, prevalence of osteoporosis investigation, and prevalence of osteoporosis diagnosis based on the clinical subspecialty involved. There were 311 patients evaluated in the initial phase, and 226 after rehabilitation. The mortality rate was 5.8% (10% for men, 4% for women; p<0.005) in the acute care hospital and 9.3% (8% men, 10% women) during rehabilitation. Previous hip fracture occurred in 17.4%, and 1.5% were readmitted during the study period with fracture of the opposite hip. Osteoporosis was diagnosed in the acute care hospital on admission in 11.9% and on discharge in 15.4%. In the rehabilitation hospital it was diagnosed in 9.7% on admission and 11.2% on discharge (p=NS). Osteoporosis treatment (including calcium or vitamin D therapy) was instituted in 13% on admission to acute care and in 9.7% at the time of discharge. For the rehabilitation hospital, treatment occurred in 12.8% on admission and 10.2% on discharge. The diagnosis of osteoporosis significantly increased the prevalence of treatment (p<0.001). Use of specific agents (hormone replacement therapy, bisphosphonates or calcitonin) occurred in <66% of all patients. Osteoporosis is under-diagnosed and under-treated in this group of elderly hip fracture patients. It is associated with significant mortality and morbidity and every effort should be made to prevent future fractures. Physicians in the 'front line' of hip fracture treatment are missing this key aspect of management in their patients. Education of these physicians, as well as the public, may be the key to addressing this care gap.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991439     DOI: 10.1007/s001980200015

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  50 in total

1.  Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system.

Authors:  A Shibli-Rahhal; M S Vaughan-Sarrazin; K Richardson; P Cram
Journal:  Osteoporos Int       Date:  2011-01-27       Impact factor: 4.507

2.  The management of osteoporosis following hip fracture: how to improve our care.

Authors:  Alexander A Fisher; Michael W Davis; Marc M Budge
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

3.  Appraising osteoporosis care gaps.

Authors:  Thomas P Olenginski; Jana L Antohe; Elaine Sunderlin; Thomas M Harrington
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

4.  Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention.

Authors:  Deborah A Levine; Kenneth G Saag; Linda L Casebeer; Cathleen Colon-Emeric; Kenneth W Lyles; Richard M Shewchuk
Journal:  J Am Med Dir Assoc       Date:  2006-07-17       Impact factor: 4.669

5.  A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service.

Authors:  William D Leslie; Leonard MacWilliam; Lisa Lix; Patricia Caetano; Gregory S Finlayson
Journal:  Osteoporos Int       Date:  2004-10-02       Impact factor: 4.507

6.  Treatment for older men with fractures.

Authors:  A J Shepherd; A R Cass; L A Ray; A Tan; G S Wilkinson
Journal:  Osteoporos Int       Date:  2011-08-03       Impact factor: 4.507

7.  Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures.

Authors:  Yair Liel; Hana Castel; Dan Y Bonneh
Journal:  Osteoporos Int       Date:  2003-04-18       Impact factor: 4.507

Review 8.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

Review 9.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

10.  The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC).

Authors:  George Ioannidis; Alexandra Papaioannou; Lehana Thabane; Amiram Gafni; Anthony Hodsman; Brent Kvern; Aleksandra Walsh; Famida Jiwa; Jonathan D Adachi
Journal:  BMC Med Educ       Date:  2009-08-06       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.